Proshares Trust ZBIO
ZBIO
$26.87 -1.36 (-4.82%)
At close: Oct 23, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Sale and Maturity of Investments (2025 - 2026)

Updated

Analysis

Zenas BioPharma (ZBIO) Sale and Maturity of Investments (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Zenas BioPharma 1.70 Bn 1.03 Bn - 74.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.11 Mn
Mar 31, 2026 108.13 Mn
Dec 31, 2025 69.53 Mn
Sep 30, 2025 104.24 Mn
Jun 30, 2025 14.26 Mn
Mar 31, 2025 12.86 Mn
API Access

Zenas BioPharma Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ZBIO&period=max&api_key=YOUR_API_KEY